Pfizer nears $14 billion deal for Medivation-source

Aug 21 (Reuters) - Pfizer Inc is in advanced talks

to acquire U.S. cancer drug company Medivation Inc for

close to $14 billion, as it seeks to boost its oncology

portfolio, a person familiar with the matter said on Sunday.

Read more